Eortc MoBilE Device (EMBED)
Starting soon
Conditions studied: Diagnosis of Cancer
In brief
This study is a longitudinal observational study that will investigate the feasibility of using mobile devices for the assessment of HRQoL and physical activity in adult cancer patients undergoing treatment. Patients will complete a set of patient reported outcome measures (PROMs), and wear a smartwatch (min. 10 hours per day for one week), at baseline, and at weeks 4, 8 and 12 after treatment start.
Key facts
- Study ID
- NCT07711080
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
- People needed
- 137
- Starts
- 2026-09-01
- Expected to finish
- 2028-09-01
- Last updated by the study team
- 2026-07-17
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis of cancer
- Age≥18
- Starting a first or new anticancer treatment within one month following enrolment
- Literacy in the target language
- Ability to understand and fill out questionnaires
- Ability to operate a smartphone
- In possession of a smartphone allowing for an internet connection and willing to use this device to submit data
- Written informed consent
- Life expectancy>3 months
You may not qualify if…
- Exclusively receiving palliative care
- Start of cancer-related treatment < 1 week from time of screening
- Any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule; those conditions should be assessed and discussed with the patient before enrolment in this study.
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.